相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CNS vasculitis in a patient with MS on daclizumab monotherapy
Joan Ohayon et al.
NEUROLOGY (2013)
Lymphoid tissue inducer cells: innate cells critical for CD4(+) T cell memory responses?
Peter J. L. Lane et al.
YEAR IN IMMUNOLOGY (2012)
Natural killer cells act as rheostats modulating antiviral T cells
Stephen N. Waggoner et al.
NATURE (2012)
Preparing for Precision Medicine
Reza Mirnezami et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
Justin S. A. Perry et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Interleukin-2/Interleukin-2 Antibody Therapy Induces Target Organ Natural Killer Cells That Inhibit Central Nervous System Inflammation
Junwei Hao et al.
ANNALS OF NEUROLOGY (2011)
Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
Amy E. Lovett-Racke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Boosting Signal-to-Noise in Complex Biology: Prior Knowledge Is Power
Trey Ideker et al.
CELL (2011)
In Silico Augmentation of the Drug Development Pipeline: Examples From the Study of Acute Inflammation
Gary An et al.
DRUG DEVELOPMENT RESEARCH (2011)
Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
Wenzheng Jiang et al.
JOURNAL OF IMMUNOLOGY (2011)
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Kerstin Berer et al.
NATURE (2011)
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy
Simone C. Wuest et al.
NATURE MEDICINE (2011)
Intrathecal effects of daclizumab treatment of multiple sclerosis
B. Bielekova et al.
NEUROLOGY (2011)
Systems biology of ageing and longevity
Thomas B. L. Kirkwood
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies
Marcelo C. Pasquini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Systems Biology: An Approach
P. Kohl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Regulated Expression of Nuclear Receptor RORγt Confers Distinct Functional Fates to NK Cell Receptor-Expressing RORγt+ Innate Lymphocytes
Cedric Vonarbourg et al.
IMMUNITY (2010)
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Hsin-Jung Wu et al.
IMMUNITY (2010)
An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
Jayne F. Martin et al.
JOURNAL OF IMMUNOLOGY (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. (vol 9, pg 381, 2010)
D. Wynn et al.
LANCET NEUROLOGY (2010)
Visualization of omics data for systems biology
Nils Gehlenborg et al.
NATURE METHODS (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Daniel Wynn et al.
LANCET NEUROLOGY (2010)
Systems Biology and Its Application to the Understanding of Neurological Diseases
Pablo Villoslada et al.
ANNALS OF NEUROLOGY (2009)
Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Unsong Oh et al.
ARCHIVES OF NEUROLOGY (2009)
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+Foxp3 expression in subjects with multiple sclerosis
Arthur A. Vandenbark et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
The aging brain
Bruce A. Yankner et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Translational systems biology of inflammation
Yoram Vodovotz et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
Imke Metz et al.
BRAIN (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis
Sergio E. Baranzini
AUTOIMMUNITY (2006)
Dynamics of biological systems: role of systems biology in medical research
Heike E. Assmus et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
The window of therapeutic opportunity in multiple sclerosis
AJ Coles et al.
JOURNAL OF NEUROLOGY (2006)
In silico design of clinical trials:: A method coming of age
G Clermont et al.
CRITICAL CARE MEDICINE (2004)
Systems biology in drug discovery
EC Butcher et al.
NATURE BIOTECHNOLOGY (2004)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Unfolding the role of protein misfolding in neurodegenerative diseases
C Soto
NATURE REVIEWS NEUROSCIENCE (2003)
IL-15Rα recycles and presents IL-15 in trans to neighboring cells
S Dubois et al.
IMMUNITY (2002)
Reverse engineering of biological complexity
ME Csete et al.
SCIENCE (2002)
Therapeutic approaches in multiple sclerosis - Lessons from failed and interrupted treatment trials
H Wiendl et al.
BIODRUGS (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Integrated genomic and proteomic analyses of a systematically perturbed metabolic network
T Ideker et al.
SCIENCE (2001)
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
RS Wildin et al.
NATURE GENETICS (2001)
分享论文
